Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Topical Therapy for Treating Squamous Cell Carcinoma in Situ

Riya Gandhi, MA, Associate Editor

In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.”

Emily Ruiz, MD, MPH, is an associate physician at the Mohs and Dermatologic Surgery Center of Brigham and Women’s Faulkner Hospital in Boston, MA. She is also an assistant professor of dermatology at Harvard Medical School in Boston, MA, and director of the High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Hospital in Boston, MA.


Transcript coming soon!

Advertisement

Advertisement

Advertisement